S100B and COVID-19: While prior meta-analyses and systematic reviews have primarily focused on the role of cytokines or individual interleukins, such as IL-6, in predicting COVID-19 severity, there is limited consolidated evidence on both S100 proteins and interleukins as a combined biomarker profile.